Citation Impact
Citing Papers
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer
2007
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
2008
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Signalling and survival pathways in multiple myeloma
2006
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Distinct fibroblast lineages determine dermal architecture in skin development and repair
2013 StandoutNature
Increased Dickkopf-1 expression in breast cancer bone metastases
2007
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
2009
Role of wnts in prostate cancer bone metastases
2005
Cancer to bone: a fatal attraction
2011 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
2007
Cancer Metastasis: Building a Framework
2006 Standout
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
2011
Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
2007
Precision Diagnosis and Treatment for Advanced Non–Small-Cell Lung Cancer
2017
Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6
2008
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Non-hematopoietic bone marrow stem cells: Molecular control of expansion and differentiation
2005
Pathogenesis of myeloma bone disease
2008
Wnt signaling in osteoblasts and bone diseases
2004
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
IRF4 addiction in multiple myeloma
2008 Nature
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging
2009
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
2008
Skeletal remodeling in health and disease
2007 Standout
WNT signalling in the immune system: WNT is spreading its wings
2008
Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
2007
Wnt/β-Catenin Signaling and Disease
2012 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Wnt signaling as a therapeutic target for bone diseases
2009
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Genetic events in the pathogenesis of multiple myeloma
2007
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging
2011
Emerging Biological Principles of Metastasis
2017 Standout
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
Wnt/β-Catenin Signaling in Development and Disease
2006 Standout
The Application of Target Information and Preclinical Pharmacokinetic/Pharmacodynamic Modeling in Predicting Clinical Doses of a Dickkopf-1 Antibody for Osteoporosis
2010
Surrogate Wnt agonists that phenocopy canonical Wnt and β-catenin signalling
2017 StandoutNatureNobel
Applications of machine learning in drug discovery and development
2019 Standout
Clonal evolution in cancer
2012 StandoutNature
Mechanisms of Bone Metastasis
2004 Standout
The molecular characterization and clinical management of multiple myeloma in the post-genome era
2009
Osteoclast-derived activity in the coupling of bone formation to resorption
2005
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Wnt signalling in stem cells and cancer
2005 StandoutNature
Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib
2015
Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake
2011
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
2010
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
2004
Dickkopf-1 is a master regulator of joint remodeling
2007
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The cancer genome
2009 StandoutNature
Dihydrotestosterone-Inducible Dickkopf 1 from Balding Dermal Papilla Cells Causes Apoptosis in Follicular Keratinocytes
2007
Osteoblasts in prostate cancer metastasis to bone
2005
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Risk of Malignancy in Thyroid Incidentalomas Detected by 18 F-Fluorodeoxyglucose Positron Emission Tomography: A Systematic Review
2012
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
2010
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Superior results of Total Therapy 3 (2003-33) in gene expression profiling–defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance
2010
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
2009
Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone Formation
2006
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Reduced Affinity to and Inhibition by DKK1 Form a Common Mechanism by Which High Bone Mass-Associated Missense Mutations in LRP5 Affect Canonical Wnt Signaling
2005
Targeting the bone marrow microenvironment in multiple myeloma
2014
Frizzled 9 knock-out mice have abnormal B-cell development
2004
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Multiple Myeloma
2010
Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
2006
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
2017
Cancer Genome Landscapes
2013 StandoutScience
How I treat multiple myeloma in younger patients
2009
Geometric cues for directing the differentiation of mesenchymal stem cells
2010 Standout
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Multiple Myeloma
2011 Standout
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Macrophages modulate adult zebrafish tail fin regeneration
2014
Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2
2005
TOPGAL Mice Show That the Canonical Wnt Signaling Pathway Is Active During Bone Development and Growth and Is Activated by Mechanical Loading In Vitro
2005
Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment
2007
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib
2006
Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
2006
Works of Ronald C. Walker being referenced
The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma
2003
Advanced Imaging (Positron Emission Tomography and Magnetic Resonance Imaging) and Image-Guided Biopsy in Initial Staging and Monitoring of Therapy of Lung Cancer
2013
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
2009
Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
2006
Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules
2016
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
2006
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
2005
Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications
2007
The molecular classification of multiple myeloma
2006
Avascular Necrosis of Femoral and/or Humeral Heads in Multiple Myeloma: Results of a Prospective Study of Patients Treated With Dexamethasone-Based Regimens and High-Dose Chemotherapy
2005
Myeloma and bone disease: "the dangerous tango".
2006
Indeterminate Pulmonary Nodules: Risk for Having or for Developing Lung Cancer?
2014
Incidence of Thyroid Carcinoma in Fluorodeoxyglucose Positron Emission Tomography‐Positive Thyroid Incidentalomas
2007